Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Making room for T cells
Gabriel N. Maine, James J. Mulé
Gabriel N. Maine, James J. Mulé
Published July 15, 2002
Citation Information: J Clin Invest. 2002;110(2):157-159. https://doi.org/10.1172/JCI16166.
View: Text | PDF
Commentary

Making room for T cells

  • Text
  • PDF
Abstract

Commentary

Authors

Gabriel N. Maine, James J. Mulé

×

Total citations by year

Year: 2023 2022 2021 2018 2012 2011 2010 2009 2008 2007 2005 2004 2003 Total
Citations: 1 1 1 1 1 3 2 1 2 5 4 1 2 25
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (25)

Title and authors Publication Year
CD8+ T cells directed against a neuron-restricted antigen surveil the healthy CNS and injure axons following demyelination.
Benjamin Clarkson, Ethan Grund, Miranda Standiford, Kanish Mirchia, Charles Howe
Journal of Clinical Investigation 2023
Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing Rag1 Knock-Out Mice
Kim SH, Go EM, Shin DH, Choi BK, Han C
Cells 2022
Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rαhi CD8+ T cells
SH Kim, E Cho, YI Kim, C Han, BK Choi, BS Kwon
Nature Communications 2021
Intra-arterial Versus Intravenous Adoptive Cell Therapy in a Mouse Tumor Model:
A Visioni, M Kim, C Wilfong, A Blum, C Powers, D Fisher, E Gabriel, J Skitzki
Journal of immunotherapy (Hagerstown, Md. : 1997) 2018
Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma.
Munger CM, Hegde GV, Weisenburger DD, Vose JM, Joshi SS
Cancer Immunology, Immunotherapy 2012
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
MA Geller, S Cooley, PL Judson, R Ghebre, LF Carson, PA Argenta, AL Jonson, A Panoskaltsis-Mortari, J Curtsinger, D McKenna, K Dusenbery, R Bliss, LS Downs, JS Miller
Cytotherapy 2011
Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy
E Proietti, F Moschella, I Capone, F Belardelli
Molecular Oncology 2011
Activating Systemic T-Cell Immunity Against Self Tumor Antigens to Support Oncolytic Virotherapy with Vesicular Stomatitis Virus
P Wongthida, RM Diaz, C Pulido, D Rommelfanger, F Galivo, K Kaluza, T Kottke, J Thompson, A Melcher, R Vile
Human Gene Therapy 2011
Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery
KS Gunturu, KR Meehan, TA Mackenzie, TS Crocenzi, D McDermott, EJ Usherwood, KA Margolin, NA Crosby, MB Atkins, MJ Turk, C Ahonen, S Fuse, JI Clark, JL Fisher, RJ Noelle, MS Ernstoff
Journal of Clinical Oncology 2010
Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatorycells
R Liu, S Xiong, L Zhang, Y Chu
Cellular and Molecular Immunology 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
From the Cover: Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
DC Palmer, CC Chan, L Gattinoni, C Wrzesinski, CM Paulos, CS Hinrichs, DJ Powell, CA Klebanoff, SE Finkelstein, RN Fariss, Z Yu, RB Nussenblatt, SA Rosenberg, NP Restifo
Proceedings of the National Academy of Sciences 2008
Immunotherapy of malignant brain tumors
DA Mitchell, PE Fecci, JH Sampson
Immunological Reviews 2008
Hematopoietic stem cells promote the expansion and function of adoptively transferred anti-tumor CD8+ T cells
Claudia Wrzesinski, Chrystal M Paulos, Luca Gattinoni, Douglas C. Palmer, Andrew Kaiser , Zhiya Yu, Steven A. Rosenberg and Nicholas P. Restifo
Journal of Clinical Investigation 2007
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via toll-like receptor 4 signaling
Chrystal M. Paulos, Claudia Wrzesinski, Andrew Kaiser, Christian S. Hinrichs, Marcello Chieppa, Lydie Cassard, Douglas C. Palmer, Andrea Boni, Pawel Muranski, Zhiya Yu, Luca Gattinoni, Paul A. Antony, Steven A. Rosenberg, and Nicholas P. Restifo
Journal of Clinical Investigation 2007
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone
JS Miller, DJ Weisdorf, LJ Burns, A Slungaard, JE Wagner, MR Verneris, S Cooley, R Wangen, SK Fautsch, R Nicklow, T Defor, BR Blazar
Blood 2007
Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response
D Rüttinger, NK van den Engel, H Winter, M Schlemmer, H Pohla, S Grützner, B Wagner, DJ Schendel, BA Fox, KW Jauch, RA Hatz
Journal of Translational Medicine 2007
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction
Nechushtan H, Pham D, Zhang Y, Morgensztern D, Yi KH, Shin SU, Federoff HJ, Bowers WJ, Tolba KA, Rosenblatt JD
Cancer Immunology, Immunotherapy 2007
Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing
LX Wang, R Li, G Yang, M Lim, A O'Hara, Y Chu, BA Fox, NP Restifo, WJ Urba, HM Hu
Cancer research 2005
Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives
R Baccala, R Gonzalez-Quintial, W Dummer, AN Theofilopoulos
Springer Seminars in Immunopathology 2005
DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4 T cells and CD8 T cells
M Miyazaki, T Nakatsura, K Yokomine, S Senju, M Monji, S Hosaka, H Komori, Y Yoshitake, Y Motomura, M Minohara, T Kubo, K Ishihara, T Hatayama, M Ogawa, Y Nishimura
Cancer Science 2005
Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity.
Adler AJ
Current immunology reviews 2005
In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.
Mihalyo MA, Doody AD, McAleer JP, Nowak EC, Long M, Yang Y, Adler AJ
Journal of immunology (Baltimore, Md. : 1950) 2004
Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news?
R Handgretinger, W Leung, K Ihm, P Lang, T Klingebiel, D Niethammer
British Journal of Cancer 2003
Adoptive-cell-transfer therapy for the treatment of patients with cancer
ME Dudley, SA Rosenberg
Nature Reviews Cancer 2003

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts